Floatz logo

Tesamorelin

Metabolic Dysfunction-Associated Steatotic Liver Disease

Hudson Biotechprotein_peptidePhase 2Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

130 Active assets in the Metabolic Dysfunction-Associated Steatotic Liver Disease cohort.

Asset / SponsorPhaseRating
Dapagliflozin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4BBB
Exenatide
Fudan University
Phase 4BBB
Metformin
Xiqiao Zhou
Phase 4BBB
Empagliflozin
Justin Ryder
Phase 4BBB
Pioglitazone
Badr University
Phase 4BBB

View all 50 →

Same molecule, other indications

Tesamorelin is also rated in:

lipodystrophyDormant
B
Indicative · Phase 3
62 / 100
View asset →
isolated congenital growth hormone deficiencyDormant
B
Indicative · Phase 4
60 / 100
View asset →
HIV infectious diseaseDormant
B
Indicative · Phase 3
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →